An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection-Reference-Cited by-同舟云学术

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection

Published:2016-03-19 Issue:17 Volume:7 Page:24097-24110
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ao Lu¹²,Song Xuekun¹,Li Xiangyu²,Tong Mengsha²,Guo You²,Li Jing²,Li Hongdong²,Cai Hao²,Li Mengyao²,Guan Qingzhou²,Yan Haidan²,Guo Zheng¹²

Affiliation:

1. College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, China

2. Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Department of Bioinformatics, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350001, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of machine learning-based predictors for early diagnosis of hepatocellular carcinoma;Scientific Reports;2024-03-04

2. The Strategies and Progression in The Stratification of Hepatocellular Carcinoma Using Multi-omics Data;PROG BIOCHEM BIOPHYS;2023

3. Research Progress in Evaluating the Value of Several Types of Inflammation Scores after Liver Cell Resection Surgery;Advances in Clinical Medicine;2023

4. Artificial intelligence using multiomics/genetic tools and application in liver disease;Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases;2023

5. A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma;Cancer Cell International;2022-02-22